SCHEMBL22556823

SCHEMBL22556823

CC(C)(C)OC(=O)N1CCN(C2CC(C=O)C2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
EPHX2 P34913 1/20 0.45
HPGD P15428 1/20 0.42
ALDH1A1 P00352 2/20 0.41
HTT P42858 2/20 0.41
ATM Q13315 1/20 0.41
RECQL P46063 1/20 0.40
EPHX1 P07099 1/20 0.40
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NR1H2 P55055 1/20 0.40
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18550789 0.90 CHRM2 (0.43) USP2SMN1; SMN2EPHX2HPGDALDH1A1
SCHEMBL22556800 0.87 HPGD (0.44) USP2SMN1; SMN2EPHX2HPGDALDH1A1
SCHEMBL22556801 0.87 HPGD (0.44) USP2SMN1; SMN2EPHX2HPGDALDH1A1
SCHEMBL21852667 0.83 CHRM2 (0.58) USP2SMN1; SMN2EPHX2HPGDALDH1A1
SCHEMBL13568032 0.83 CHRM2 (0.58) USP2SMN1; SMN2EPHX2HPGDALDH1A1
SCHEMBL24764754 0.83 CHRM2 (0.58) USP2SMN1; SMN2EPHX2HPGDALDH1A1
SCHEMBL22565928 0.83 USP2 (0.49) USP2SMN1; SMN2EPHX2HPGDALDH1A1
SCHEMBL26766586 0.83 USP2 (0.49) USP2SMN1; SMN2EPHX2HPGDALDH1A1
SCHEMBL25273083 0.81 USP2 (0.47) USP2SMN1; SMN2EPHX2HPGDALDH1A1
SCHEMBL6976084 0.81 CHRM2 (0.43) USP2SMN1; SMN2EPHX2HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111825657-A Dual-function chimeric heterocyclic compound for targeted degradation of androgen receptor and application thereof 成都海创药业有限公司 2020-10-27 CN disclosed
WO-2020211822-A1 A CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DEGRADATION OF ANDROGEN RECEPTORS AND USE THEREOF 成都海创药业有限公司 2020-10-22 WO disclosed
WO-2020211822-A1 A CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DEGRADATION OF ANDROGEN RECEPTORS AND USE THEREOF 成都海创药业有限公司 2020-10-22 WO disclosed